Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Glatiramer-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sirolimus (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sirolimus 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sirolimus 1mg/sachet oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sirolimus 2mg/sachet oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sirolimus 1mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sirolimus 1mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glatiramer acetate 20mg/vial injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glatiramer acetate 20 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Glatiramer acetate 20mg/vial injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sirolimus 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sirolimus 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sirolimus 140mcg/cc drug eluting stent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Blood sirolimus measurement |
Component |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Measurement of sirolimus (procedure) |
Component |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sirolimus therapy (procedure) |
Direct substance |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Sirolimus 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sirolimus 1 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sirolimus 2 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sirolimus 2 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing sirolimus in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sirolimus 2 mg oral tablet |
Has precise active ingredient |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sirolimus 1 mg oral tablet |
Has precise active ingredient |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sirolimus 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has precise active ingredient |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely sirolimus 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sirolimus (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only sirolimus in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Sirolimus 140 microgram/cm2 drug eluting stent (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Blood sirolimus measurement |
Component |
True |
Sirolimus (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |